The Traditional Medicine and Drug Development Programme (TMDDP) is one of the six research programmes of the Kenya Medical Research Institute (KEMRI). The Programme is aligned to the Institute’s Strategic Master Plan and the Kenya Vision 2030. The Programme was established in the 2011/2012 financial year.
To be a leading programme in the promotion of Traditional Medicine and Drug Development
To improve human health and quality of life though promotion and development of safe, efficacious and quality Traditional Medicines and Drugs
To identify and develop effective traditional/alternative medicines and drugs for use against human diseases in partnership with relevant institutions and Government minis-tries. In addition, the programme is also in-tended to provide information on quality of selected drugs in the Kenyan market.
- To facilitate the identification, documentation and conservation of Medicinal Plants in Kenya.
- To facilitate the determination of the quality, safety and efficacy of Traditional Medicines (TM) in Kenya.
- To facilitate pilot production of validated TM.
- To strengthen capacity building and training in TM.
- To play a role in the advisory and policy formulation in Traditional Medicine.
- To support the determination of the quality of drugs in the Kenyan market.
PROGRAMME GOALS AND OBJECTIVES
Goal 1: Identify and develop sustainable safe and effective TM for use against human diseases.
- Identify and document TM used for various diseases.
- Promote development of relevant policies & legal frameworks of TM.
- Facilitate determination of quality, safety and efficacy of TM.
- To promote conservation of medicinal plants used to make TMs.
- To act as advisory body to the MOH on TM.
- To strengthen partnerships with other stakeholders.
- To translate research into model phytomedicines.
- To initiate and support human development (capacity building) on TM research.
Goal 2: Identify factors that influence quality of pharmaceutical products in Kenya.
- Identify problematic drugs whose qualities easily deteriorate.
- Determine factors that contribute to the deterioration.
EXPECTED PROGRAMME OUTPUT
- Increased documentation of medicinal plants and traditional medicines.
- Pilot production of validated phytomedicines.
- Increased research development, dissemi-nation and utility of TM.
- Increased resource mobilization.
- Strengthened partnerships with other stakeholders.
- Increased human resource capacity in the area of TM.
PROGRAMME CONTRIBUTION TO GOALS & OBJECTIVES OF THE HEALTH SECTOR-KENYA VISION 2030, NATIONAL DEVELOPMENT AGENGA
- Promote use of safe and effective TM.
- Increased knowledge, attitude and practice on TM.
- Influence policies on TM.
- Increased alternative sources of health care.
PARTNERS AND COLLABORATORS
- Government departments: Ministries of Health, Ministry of Culture and Social Services, NACOSTI , KIRDI, NMK, KCDA and KARI.
- Non-governmental Organizations: ANAMED & PROMETRA
- Institutions of higher learning: JKUAT, KU, UoN, Maseno University, Makerere University, University of Dar es Saalam, Muhimbili University, University of Ibadan, Cameroon University.
- International organizations: (ICIPE), Japan International Cooperation Agency (JICA), World Health Organization (WHO), IPR
Traditional Medicine and Drug Development Programme,
Kenya Medical Research Institute,
P.O Box, 54840-00200, Nairobi, KENYA
Office Tel: (254) (020) 2722541, Ext. 3324
Fax: (254) (020) 2720030